EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ADAM-17 Activity and Its Relation to ACE2: Implications for Severe COVID-19

Jiangming Sun iD, Andreas Edsfeldt, Joel Svensson, Toralph Ruge, Isabel Goncalves, Per Swärd iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25115911 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Jiangming Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research-Translational Studies, Department of Clinical Sciences Malmö, Lund University, 205 02 Malmö, Sweden. Hauptthemen laut MEDLINE: COVID-19, ADAM17 Protein, Angiotensin-Converting Enzyme 2, SARS-CoV-2. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kockska foundation, Swedish research foundation, Swedish heart and lung foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is a lack of studies aiming to assess cellular a disintegrin and metalloproteinase-17 (ADAM-17) activity in COVID-19 patients and the eventual associations with the shedding of membrane-bound angiotensin-converting enzyme 2 (mACE2). In addition, studies that investigate the relationship between ACE2 and ADAM-17 gene expressions in organs infected by SARS-CoV-2 are lacking. We used data from the Massachusetts general hospital COVID-19 study (306 COVID-19 patients and 78 symptomatic controls) to investigate the association between plasma levels of 33 different ADAM-17 substrates and COVID-19 severity and mortality. As a surrogate of cellular ADAM-17 activity, an ADAM-17 substrate score was calculated. The associations between soluble ACE2 (sACE2) and the ADAM-17 substrate score, renin, key inflammatory markers, and lung injury markers were investigated. Furthermore, we used data from the Genotype-Tissue Expression (GTEx) database to evaluate ADAM-17 and ACE2 gene expressions by age and sex in ages between 20–80 years. We found that increased ADAM-17 activity, as estimated by the ADAM-17 substrates score, was associated with COVID-19 severity (p = 0.001). ADAM-17 activity was also associated with increased mortality but did not reach statistical significance (p = 0.06). Soluble ACE2 showed the strongest positive correlation with the ADAM-17 substrate score, follow by renin, interleukin-6, and lung injury biomarkers. The ratio of ADAM-17 to ACE2 gene expression was highest in the lung. This study indicates that increased ADAM-17 activity is associated with severe COVID-19. Our findings also indicate that there may a bidirectional relationship between membrane-bound ACE2 shedding via increased ADAM-17 activity, dysregulated renin–angiotensin system (RAS) and immune signaling. Additionally, differences in ACE2 and ADAM-17 gene expressions between different tissues may be of importance in explaining why the lung is the organ most severely affected by COVID-19, but this requires further evaluation in prospective studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19ADAM17 ProteinAngiotensin-Converting Enzyme 2SARS-CoV-2Severity of Illness IndexHumansMiddle AgedFemaleMaleAgedAdultAged, 80 and overYoung AdultBiomarkers

Stichwörter der Autor:innen

a disintegrin and metalloproteinase-17angiotensin-converting enzyme 2coronavirus disease 2019severe acute respiratory syndrome coronavirus 2

Substanzen

ADAM17 ProteinAngiotensin-Converting Enzyme 2ADAM17 protein, humanACE2 protein, humanBiomarkers

Autor:innen und Institutionen

  • Cardiovascular Research-Translational Studies, Department of Clinical Sciences Malmö, Lund University, 205 02 Malmö, Sweden.
  • Department of Cardiology, Skåne University Hospital, 205 02 Malmö, Sweden.
  • Wallenberg Center for Molecular Medicine, Lund University, 221 00 Lund, Sweden.
  • Department of Laboratory Medicine, Lund University, 221 00 Lund, Sweden.
  • Department of Emergency and Internal Medicine, Skånes University Hospital, 214 28 Malmö, Sweden.
  • Department of Clinical Sciences Malmö, Lund University, 214 28 Malmö, Sweden.

ORCID-Profile: Jiangming Sun, Per Swärd

Förderung

  • Kockska foundation
  • Swedish research foundation
  • Swedish heart and lung foundation
  • Swedish society for Medical Research
  • Swedish society of Medicine
  • Emil and Wera Cornell foundation
  • ALF grants Region Skåne
  • Crawfoord foundation

Zitieren

APA

Sun, J., Edsfeldt, A., Svensson, J., Ruge, T., Goncalves, I., & Swärd, P. (2024). ADAM-17 Activity and Its Relation to ACE2: Implications for Severe COVID-19. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25115911

Vancouver

Sun J, Edsfeldt A, Svensson J, Ruge T, Goncalves I, Swärd P. ADAM-17 Activity and Its Relation to ACE2: Implications for Severe COVID-19. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25115911

BibTeX
@article{Sun2024,
  author = {Sun, Jiangming and Edsfeldt, Andreas and Svensson, Joel and Ruge, Toralph and Goncalves, Isabel and Swärd, Per},
  title = {ADAM-17 Activity and Its Relation to ACE2: Implications for Severe COVID-19},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25115911}
}
Kostenlos starten →